Kawano Yumeko, Weber Brittany N, Weisenfeld Dana, Jeffway Mary I, Cai Tianrun, McDermott Gregory C, Liu Qing, Sparks Jeffrey A, Stuart Jennifer, Joseph Jacob, Cai Tianxi, Liao Katherine P
Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Brigham and Women's Hospital, Boston, Massachusetts.
Arthritis Care Res (Hoboken). 2025 May;77(5):631-639. doi: 10.1002/acr.25481. Epub 2025 Jan 16.
Patients with rheumatoid arthritis (RA) are at increased risk of cardiovascular disease (CVD) including heart failure (HF). However, little is known regarding the relative risks of HF subtypes such as HF with preserved ejection fraction (HFpEF) or reduced ejection fraction (HFrEF) in RA compared with non-RA.
We identified patients with RA and matched non-RA comparators among participants consenting to broad research from two large academic centers. We identified incident HF and categorized HF subtypes based on EF closest to the HF incident date. Covariates included age, sex, and established CVD risk factors. Cox proportional hazards models were used to estimate the hazard ratios (HRs) for incident HF and HF subtypes.
We studied 1,445 patients with RA and 4,335 matched non-RA comparators (mean age 51.4 and 51.7 years, respectively; 78.7% female). HFpEF was the most common HF subtype in both groups (65% in RA vs 59% in non-RA). Patients with RA had an HR of 1.79 (95% confidence interval [CI] 1.38-2.32) for incident HF compared with those without RA after adjusting for CVD risk factors. Patients with RA had a higher rate of HFpEF (HR 1.99, 95% CI 1.43-2.77), but there was no statistical difference in the HFrEF rate (HR 1.45, 95% CI 0.81-2.60).
RA was associated with a higher rate of HF overall compared with non-RA, even after adjustment for established CVD risk factors. The elevated risk was driven by HFpEF, supporting a role for inflammation in HFpEF and highlighting potential opportunities to address this excess risk in RA.
类风湿关节炎(RA)患者发生心血管疾病(CVD)包括心力衰竭(HF)的风险增加。然而,与非RA患者相比,RA患者中射血分数保留的心力衰竭(HFpEF)或射血分数降低的心力衰竭(HFrEF)等HF亚型的相对风险知之甚少。
我们在两个大型学术中心同意广泛研究的参与者中确定了RA患者并匹配了非RA对照者。我们确定了新发HF,并根据最接近HF发病日期的射血分数对HF亚型进行分类。协变量包括年龄、性别和已确定的CVD危险因素。使用Cox比例风险模型估计新发HF和HF亚型的风险比(HR)。
我们研究了1445例RA患者和4335例匹配的非RA对照者(平均年龄分别为51.4岁和51.7岁;78.7%为女性)。HFpEF是两组中最常见的HF亚型(RA组为65%,非RA组为59%)。在调整CVD危险因素后,与无RA的患者相比,RA患者发生HF的HR为1.79(95%置信区间[CI]1.38 - 2.32)。RA患者的HFpEF发生率较高(HR 1.99,95%CI 1.43 - 2.77),但HFrEF发生率无统计学差异(HR 1.45,95%CI 0.81 - 2.60)。
即使在调整已确定的CVD危险因素后,与非RA相比,RA总体上与更高的HF发生率相关。风险升高是由HFpEF驱动的,这支持炎症在HFpEF中的作用,并突出了解决RA中这种额外风险的潜在机会。